Atai Beckley, Inc. (ATAI)
7.35
0.00 (0.00%)
USD |
NASDAQ |
Sep 11, 16:00
Atai Beckley Enterprise Value : 2.490B for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 2.490B |
| September 10, 2026 | 2.490B |
| September 09, 2026 | 2.468B |
| September 08, 2026 | 2.464B |
| September 04, 2026 | 2.505B |
| September 03, 2026 | 2.486B |
| September 02, 2026 | 2.490B |
| September 01, 2026 | 2.486B |
| August 31, 2026 | 2.486B |
| August 28, 2026 | 2.468B |
| August 27, 2026 | 2.490B |
| August 26, 2026 | 2.505B |
| August 25, 2026 | 2.523B |
| August 24, 2026 | 2.501B |
| August 21, 2026 | 2.501B |
| August 20, 2026 | 2.516B |
| August 19, 2026 | 2.494B |
| August 18, 2026 | 2.468B |
| August 17, 2026 | 2.449B |
| August 14, 2026 | 2.457B |
| August 13, 2026 | 2.453B |
| August 12, 2026 | 2.446B |
| August 11, 2026 | 2.438B |
| August 10, 2026 | 2.453B |
| August 07, 2026 | 2.453B |
| Date | Value |
|---|---|
| August 06, 2026 | 2.427B |
| August 05, 2026 | 2.442B |
| August 04, 2026 | 2.427B |
| August 03, 2026 | 2.427B |
| July 31, 2026 | 2.427B |
| July 30, 2026 | 2.427B |
| July 29, 2026 | 2.427B |
| July 28, 2026 | 2.427B |
| July 27, 2026 | 2.423B |
| July 24, 2026 | 2.427B |
| July 23, 2026 | 2.423B |
| July 22, 2026 | 2.427B |
| July 21, 2026 | 2.410B |
| July 20, 2026 | 2.431B |
| July 17, 2026 | 2.442B |
| July 16, 2026 | 2.416B |
| July 15, 2026 | 1.755B |
| July 14, 2026 | 1.870B |
| July 13, 2026 | 1.611B |
| July 10, 2026 | 1.685B |
| July 09, 2026 | 1.744B |
| July 08, 2026 | 1.685B |
| July 07, 2026 | 1.692B |
| July 06, 2026 | 1.607B |
| July 02, 2026 | 1.692B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Eli Lilly & Co. | 1.096T |
| GH Research Plc | 1.505B |
| Johnson & Johnson | 667.86B |
| Merck & Co., Inc. | 402.09B |
| Definium Therapeutics, Inc. | 4.178B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -32.55M |
| Revenue (Quarterly) | 1.704M |
| Total Expenses (Quarterly) | 34.23M |
| EPS Diluted (Quarterly) | -0.0902 |
| Gross Profit Margin (Quarterly) | 87.38% |
| Profit Margin (Quarterly) | -1.91K% |
| Earnings Yield | -29.77% |
| Normalized Earnings Yield | -12.72 |